Creatine Kinase-MB/Cardiac Troponin I/Myoglobin(CK-MB/cTnI/Myo Fast Test Kit
- UID
- IMP/IVD/2021/000016_c04624f86f13993ec14cf75625f38966_91893308364bcb46b3160af7155c618a
- Device class
- Class C
- Brand name
- PCT
- License holder
- Akshat Bio Medicals Pvt Ltd
- Approving authority
- CDSCO
- Product information
- CK-MB/cTnl/Myo Fast Test Kit (PCT) is intended for in vitro quantitative determination of CK-MB/cTnl/Myo in serum, plasma or whole blood. This test is used as an aid in the clinical diagnosis, prognosis and evaluation of myocardial injury such as Acute Myocardial Infarction (PCT). Unstable Angina, Acute Myocarditis, and Acute Coronary Syndrome (PCT)
Creatine Kinase-MB/Cardiac Troponin I/Myoglobin(CK-MB/cTnI/Myo Fast Test Kit is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2021/000016_c04624f86f13993ec14cf75625f38966_91893308364bcb46b3160af7155c618a. This device is marketed under the brand name PCT. The license holder is Akshat Bio Medicals Pvt Ltd, and it is classified as Device Class Class C. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.